LysaghtM.J., VoneshE.F., GotchF., IbelsL., KeenM., LindholmB.The influence of dialysis treatment modality on the decline of remaining renal function.ASAIO Trans1991; 37: 598–604.
2.
MoistL.M., PortF.K., OrzolS.M., YoungE.W., OstbyeT., WolfeR.A.Predictors of loss of residual renal function among new dialysis patients.J Am Soc Nephrol2000; 11: 556–64.
3.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.R., OreopoulosD.G., PageD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada–USA (CANUSA) Peritoneal Dialysis Study Group.J Am Soc Nephrol1998; 9: 1285–92.
4.
BrownE.A., DaviesS.J., RutherfordP., MeeusF., BorrasM., RiegelW.Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study.J Am Soc Nephrol2003; 14: 2948–57.
5.
AtesK., NergizogluG., KevenK., SenA., KutlayS., ErturkS.Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.Kidney Int2001; 60: 767–76.
6.
BargmanJ.M., ThorpeK.E., ChurchillD.N.Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA Study.J Am Soc Nephrol2001; 12: 2158–62.
7.
TermorshuizenF., KorevaarJ.C., DekkerF.W., van ManenJ.G., BoeschotenE.W., KredietR.T.The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2.Am J Kidney Dis2003; 41: 1293–302.
8.
PD+HD Combination Therapy Study Group.Review of combination of peritoneal dialysis and hemodialysis as a modality of treatment for end-stage renal disease.Ther Apher Dial2004; 8: 56–61.
9.
McIntyreC.W.Bimodal dialysis: an integrated approach to renal replacement therapy.Perit Dial Int2004; 24: 547–53.
10.
IestC.G., VanholderR.C., RingoirS.M.Loss of residual renal function in patients on regular haemodialysis.Int J Artif Organs1989; 12: 159–64.
11.
HakimR.M., WingardR.L., ParkerR.A.Effect of the dialysis membrane in the treatment of patients with acute renal failure.N Engl J Med1994; 17: 1338–42.
12.
KawanishiH., MoriishiM., TsuchiyaS.Five years’ experience of combination therapy: peritoneal dialysis with hemodialysis.Adv Perit Dial2002; 18: 62–7.
13.
AgarwalM., ClinardP., BurkartJ.M.Combined peritoneal dialysis and hemodialysis: our experience compared to others.Perit Dial Int2003; 23: 157–61.
14.
FloegeJ., BartschA., SchulzeM., ShaldonS., KochK.M., SmebyL.C.Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects.J Lab Clin Med1991; 118: 153–65.
15.
HendriksP., Ho-dac-PannekeetM., van GulikT., StruijkD., PhoaS., SieL.Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics.Perit Dial Int1997; 17: 136–43.
16.
CasinoF.G., LopezT.The equivalent renal urea clearance: a new parameter to assess dialysis dose.Nephrol Dial Transplant1996; 11: 1574–81.
17.
DaviesS.J., PhillipsL., NaishP.F., RussellG.I.Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis.J Am Soc Nephrol2001; 12: 1046–51.
18.
de AlvaroF., CastroM.J., DapenaF., BajoM.A., Fernandez-ReyesM.J., RomeroJ.R.Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.Adv Perit Dial1993; 9: 56–61.
19.
HashimotoY., MatsubaraT.Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.Adv Perit Dial2000; 16: 108–12.
